Search hospitals > Tennessee > Kingsport
Ballad Health Cancer Care - Kingsport
Claim this profileKingsport, Tennessee 37660
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
61 reported clinical trials
1 medical researcher
Summary
Ballad Health Cancer Care - Kingsport is a medical facility located in Kingsport, Tennessee. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer, Lung Cancer and other specialties. Ballad Health Cancer Care - Kingsport is involved with conducting 61 clinical trials across 131 conditions. There are 1 research doctors associated with this hospital, such as Asheesh Shipstone.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
Global LeaderHER2 positive
ER positive
Stage IV
Top PIs
Clinical Trials running at Ballad Health Cancer Care - Kingsport
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Urothelial Carcinoma
Bladder Cancer
Ovarian Cancer
Fallopian Tube Cancer
Colorectal Cancer
Peritoneal Cancer
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ballad Health Cancer Care - Kingsport?
Ballad Health Cancer Care - Kingsport is a medical facility located in Kingsport, Tennessee. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer, Lung Cancer and other specialties. Ballad Health Cancer Care - Kingsport is involved with conducting 61 clinical trials across 131 conditions. There are 1 research doctors associated with this hospital, such as Asheesh Shipstone.